Meningitis, Meningococcal, Serogroup C
1 clinical trials · Condition
◉ Watch Meningitis, Meningococcal, Serogroup C
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity Study in Young Adults the Meningococcal Serogroup C Vaccine Produced by Bio-Manguinhos (NCT01889836) | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 2014-05-01 |
Track Meningitis, Meningococcal, Serogroup C automatically
Every clearance here is in the API, with alerts when new ones post.